GenomeWeb Top 40 Down 4 Percent in February, Tracking Broader Market
The Dow Jones Industrial Average was down 4 percent, while the Nasdaq was down 1 percent, and the Nasdaq Biotech Index was down 7 percent.
GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing
SomaLogic, Exact Sciences, and Myriad paced the winners in January, while Olink, a new addition to the Top 40, led decliners.
SomaLogic Expands Into Middle East With Proteomics Supply Deal for Group 42 Healthcare
G42 will be the sole laboratory partner for SomaLogic's SomaScanPlatform for the life sciences and healthcare markets in the UAE and Saudi Arabia.
SomaLogic Seeks 'Strategic Alternatives' for Dx Business to Focus on Life Science Market
The proteomics firm is in talks to either spin off its SomaSignal assays unit or to partner with another company to boost its diagnostics efforts.
Preliminary Earnings Roundup: NanoString Technologies, SomaLogic, Pacific Biosciences, More
Other firms reporting their preliminary earnings for Q4 included Akoya Biosciences, Olink, Standard BioTools, and Singular Genomics.